0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Is Long-term Levothyroxine Therapy Safe?

KENNETH D. BURMAN, MD
Arch Intern Med. 1990;150(10):2010-2013. doi:10.1001/archinte.1990.00390210012004.
Text Size: A A A
Published online

Our understanding of thyroid hormone action has increased tremendously since 1891, when George Murray1 first successfully treated a hypothyroid patient with sheep thyroid extract injections. As time and experience progressed, we have learned that the thyroid gland synthesizes and secretes two major active components, thyroxine and triiodothyronine. In fact, each of these products has been synthesized and is used now for the treatment of various clinical conditions. Presently, thyroid preparations are prescribed frequently for a variety of common clinical conditions (eg, hypothyroidism, suppression of solitary nodules, or multinodular goiter) See also pp 2077-2081. and, in 1988, accounted for about 1.3% of prescriptions filled in the United States (S. C. Kaufman, MD, T. P. Gross, MD, and D. L. Kennedy, MPH, unpublished data, 1990).2 Endocrinologists are virtually unanimous in recommending synthetic levothyroxine for long-term use, and about 70% of prescriptions written for thyroid preparations in the United States by

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 19

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();